Please refer to Table 1 and Table 2 for an overview of the clinical trials conducted in the context of oral and topical PDE4 inhibition for psoriasis with sponsors, clinical trial phases, and National Clinical Trial (NCT) numbers listed. This evidence concerns the gene PDE4A and psoriasis.